We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ONON:NYSEOn Holding AG Analysis

Data as of 2026-08-14 - not real-time

$31.57

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $31.57, On Holding AG shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have lost 14.3%. Momentum indicators put RSI at 34.8 (approaching oversold) with MACD reading bearish. Recent trading has carved out support near $30.11 and resistance around $39.05.
On valuation the read is fair — an earnings multiple of 21.3, absent a reliable peer benchmark. Consensus targets land 66.2% above where the shares trade now. Revenue is growing at 13.5% on a 12.3% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 75.4%, a beta of 1.32 and a maximum drawdown of 38.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 2/10 conviction over the longer horizon.

Top Market Events

Business Wire16dOn to Release Second Quarter 2026 Results on Tuesday, August 11, 2026ZURICH, Switzerland-- BUSINESS...On Holding stock plunged 22% after Q2 2026 revenue missed Wall Street consensus, but the selloff came from a deliberate...Hosted on MSN24dOn Holding AG ONON is attracting investor attention: Here is what you should knowOn Holding ONON is one...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 40.26
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 40.26
  • Analyst targets imply +66.2% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +66.2% versus the current price
  • Revenue growth of +13.5%
  • P/E ratio of 21.3

Key Metrics & Analysis

Financial Health

Revenue Growth13.50%
Profit Margin12.30%
P/E Ratio21.3
ROE23.95%
ROA9.58%
Debt/Equity29.43
P/B Ratio4.5
Op. Cash Flow$525.4M
Free Cash Flow$288.5M

Technical Analysis

TrendBearish
RSI34.8
Support$30.11
Resistance$39.05
MA 20$36.04
MA 50$36.78
MA 200$40.26
MACDBearish
VolumeIncreasing
Fear & Greed Index95.59

Valuation

Fair Value$21.44
Target Price$52.48
Upside/Downside66.23%
GradeFair
TypeGrowth

Risk Assessment

Beta1.32
Volatility75.38%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.